)
JBT Marel (JBTM) investor relations material
JBT Marel Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 revenue was $994M, down 0.7% YoY, while adjusted EBITDA reached a quarterly record of $179M and adjusted EBITDA margin rose 90 bps to 18.0%.
Lower CPG-related book-and-ship volume weighed on revenue; cost actions, integration progress and productivity gains supported confidence in the 2028 margin target.
Financial highlights
Adjusted EBITDA rose 5% YoY to $179M; adjusted diluted EPS increased 13% to $2.19.
Q3 net income was $70M versus $66M YoY; nine-month net income was $143M versus a $104M loss.
Nine-month revenue rose 4.3% to $2.911B and adjusted EBITDA increased 11.4% to $489M.
Q3 orders increased 3% YoY to $976M; quarter-end backlog was $1.52B versus $1.339B a year earlier.
Q3 free cash flow was $73M versus $57M YoY; nine-month free cash flow was $252M versus $163M.
Outlook and guidance
FY26 revenue guidance is $3.95B–$4.00B, implying ~5% YoY growth at midpoint, including ~1.5% FX benefit.
FY26 adjusted EBITDA margin guidance is 17.25%–17.50% and adjusted EPS guidance is $8.10–$8.40; both midpoints increased.
FY26 net income guidance is $224M–$238M, net income margin 5.6%–6.0%, adjusted EBITDA $681M–$700M and diluted EPS $4.30–$4.60.
FY28 targets include a 20% adjusted EBITDA margin and ~$150M in realized cost synergies.
DF&H weakness is expected to persist at Q3 levels through Q4; PFB is expected to return to mid-single-digit revenue growth longer term.
- Poultry demand, automation, and efficiency underpin resilient equipment and recurring-service opportunities.JBTM
Investor presentation - Record FY adjusted EBITDA and EPS; 2024 revenue guidance was $1.75B–$1.78B.JBTM
Q4 2023 - $3.9B TTM revenue, 16.4% EBITDA margin, and strong growth targets through 2028.JBTM
Investor presentation - Q2 2026 saw 5% revenue growth, strong orders, and improved margins, with guidance reaffirmed.JBTM
Q2 2026 - $3.9B TTM revenue, 16.2% EBITDA margin, and strong recurring revenue drive growth and resilience.JBTM
Investor presentation - All director nominees and proposals were approved, with no questions from stockholders.JBTM
AGM 2026 - Q1 2026 saw 10% revenue growth, $45M net income, and strong Protein Solutions margin gains.JBTM
Q1 2026 - Merger creates a global food tech leader with strong synergies, closing by year end 2024.JBTM
Business Combination - Q1 2025 revenue hit $854M, but one-time charges drove a $173M net loss; outlook cautious.JBTM
Q1 2025
)
)
)
)
)
)
)
)